Ignite Creation Date:
2024-05-06 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05257395
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-02-25
First Post:
2022-02-16
Brief Title:
A Study of XZP-3287 in Combination With LetrozoleAnastrozole in Patients With Advanced Breast Cancer
Sponsor:
Xuanzhu Biopharmaceutical Co Ltd
Organization:
Xuanzhu Biopharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-16
First Submit QC Date:
February 16 2022
Study First Post Date:
2022-02-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-16
Last Update Post Date:
2022-02-25
Last Update Post Date Type:
ACTUAL